ArticleCurrent addiction reports2026
Alcohol and Cannabis co-use and HIV risk, Treatment and Prevention Outcomes: A Scoping Review.
Article in Current addiction reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Impact of cannabis use on white matter hyperintensities in adults with and without chronic HIV disease.Journal of neurovirology · 2026Article
- Alcohol and Cannabis co-use and HIV risk, Treatment and Prevention Outcomes: A Scoping Review.Current addiction reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Purpose of Review: Alcohol and cannabis are substances commonly used by people with or made vulnerable to HIV. With changing cannabis legalization, cannabis use has been on the rise, including simultaneous use (co-use) with alcohol. Prior reviews have assessed patterns, correlates, and consequences of alcohol and cannabis co-use. We conducted a scoping review to examine alcohol and cannabis co-use and HIV risk, treatment, and prevention outcomes. Recent Findings: We identified 818 unique articles across seven databases through December 2024, of which, 28 met criteria. There was substantial heterogeneity in the conceptualization of co-use, measurement, and analysis methods. Many studies employed cluster analyses, with alcohol and cannabis co-use often included in the context of polysubstance use. Only one study utilized event-level methods to assess simultaneous use and sex behaviors. Findings on the relationship between alcohol and cannabis co-use and antiretroviral medications (ARV) outcomes and sex behaviors are mixed, though several studies suggest that co-use may be associated with poorer ARV adherence and increased engagement in sex behaviors that increased HIV risks. Summary: This review highlights substantial heterogeneity in how alcohol and cannabis co-use is conceptualized and measured. Few studies examined simultaneous use specifically or disentangle co-use from broader polysubstance patterns. Research prioritizes standardized and event-level assessment can enhance accuracy of measurement and elucidate contextual factors for alcohol and cannabis co-use. Understanding how alcohol and cannabis co-use affects populations disproportionately impacted by HIV can inform more effective and tailored HIV treatment and prevention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.